These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18075061)

  • 1. Tamiflu survives sewage treatment.
    Renner R
    Environ Sci Technol; 2007 Nov; 41(22):7591. PubMed ID: 18075061
    [No Abstract]   [Full Text] [Related]  

  • 2. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
    Straub JO
    Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
    Ghosh GC; Nakada N; Yamashita N; Tanaka H
    Environ Health Perspect; 2010 Jan; 118(1):103-7. PubMed ID: 20056566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters.
    Bartels P; von Tümpling W
    Sci Total Environ; 2008 Nov; 405(1-3):215-25. PubMed ID: 18675443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More resistance to oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of Tamiflu under pandemic conditions].
    Nau JY
    Rev Med Suisse; 2009 Jul; 5(211):1532. PubMed ID: 19694366
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of the antiviral drug oseltamivir in aquatic environments.
    Söderström H; Järhult JD; Olsen B; Lindberg RH; Tanaka H; Fick J
    PLoS One; 2009 Jun; 4(6):e6064. PubMed ID: 19557131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential risks associated with the proposed widespread use of Tamiflu.
    Singer AC; Nunn MA; Gould EA; Johnson AC
    Environ Health Perspect; 2007 Jan; 115(1):102-6. PubMed ID: 17366827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.
    Kawakami C; Obuchi M; Saikusa M; Noguchi Y; Ujike M; Odagiri T; Iwata M; Toyozawa T; Tashiro M
    Jpn J Infect Dis; 2009 Jan; 62(1):83-6. PubMed ID: 19168972
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems.
    Saccà ML; Accinelli C; Fick J; Lindberg R; Olsen B
    Chemosphere; 2009 Mar; 75(1):28-33. PubMed ID: 19124147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu.
    Nyadong L; Hohenstein EG; Johnson K; Sherrill CD; Green MD; Fernández FM
    Analyst; 2008 Nov; 133(11):1513-22. PubMed ID: 18936828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A measure of resistance: detecting Tamiflu metabolite in sewage discharge and river water.
    Tillett T
    Environ Health Perspect; 2010 Jan; 118(1):A34. PubMed ID: 20061221
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus resistance to oseltamivir: what are the implications?
    Fleming DM; Elliot AJ; Meijer A; Paget WJ
    Eur J Public Health; 2009 Jun; 19(3):238-9. PubMed ID: 19221019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial commentary: viral susceptibility and the choice of influenza antivirals.
    Monto AS
    Clin Infect Dis; 2008 Aug; 47(3):346-8. PubMed ID: 18582205
    [No Abstract]   [Full Text] [Related]  

  • 19. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of oseltamivir phosphate (Tamiflu) in human sera on results of microneutralization and hemagglutinin-inhibition tests for H5N2 avian influenza virus.
    Yamazaki Y; Doy M; Yamato S; Kawada Y; Ogata T
    Arch Virol; 2008; 153(5):945-9. PubMed ID: 18227965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.